OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Release Date
2022
(8)
2021
(8)
2023
(3)
2025
(1)
2024
(1)
2020
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
Not available
S-EPMC8041365
|
biostudies-literature
Cite
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.
Not available
S-EPMC8866425
|
biostudies-literature
Cite
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Not available
S-EPMC8185188
|
biostudies-literature
Cite
SARS-CoV-2 evolution during treatment of chronic infection.
Not available
S-EPMC7610568
|
biostudies-literature
Cite
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
Not available
S-EPMC7674007
|
biostudies-literature
Cite
Genomic reconstruction of the SARS-CoV-2 epidemic in England.
Not available
S-EPMC8674138
|
biostudies-literature
Cite
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission.
Not available
S-EPMC8826310
|
biostudies-literature
Cite
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study.
Not available
S-EPMC9240087
|
biostudies-literature
Cite
Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning.
Not available
S-EPMC9296497
|
biostudies-literature
Cite
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.
Not available
S-EPMC9352574
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets